The trademark UKENVI was filed by STADA Arzneimittel AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 28, 2022, and received one opposition filed on September 28, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 28, 2022
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, medical and veterinary preparations
Medicine
Sanitary preparations for medical purposes
Dietetic food and substances adapted for medical or veterinary use, food for babies
Diagnostic preparations
Dietary supplements for humans and animals
Plasters, materials for dressings
Material for stopping teeth, dental wax
Disinfectants
Preparations for destroying vermin
Fungicides, herbicides.
The mark was filed in class 10 with following description of goods:
Surgical, medical, dental and veterinary apparatus and instruments
Applicators for medications
Medical apparatus for introducing pharmaceutical preparations into the human body
Diagnostic apparatus for medical purposes
Artificial limbs, eyes and teeth
Orthopedic articles
Suture materials
Therapeutic and assistive devices adapted for the disabled
Massage apparatus
Apparatus, devices and articles for nursing infants